LifeVac's FDA Approval: Revolutionizing Safety Plans for Organizations

Last updated: September 1, 2026. Reviewed for regulatory accuracy against FDA, American Heart Association, and American Red Cross sources.

Anti-choking devices like LifeVac are a recognized second-line layer of choking response. They are meant to be used only after standard first aid, meaning back blows and abdominal thrusts, has failed, and they are never a replacement for CPR training or for calling 911. In March 2026, the U.S. Food and Drug Administration granted LifeVac a De Novo classification as a Class II medical device, making it the only anti-choking device the FDA has authorized for marketing in the United States as of this article's publication date. For churches, schools, restaurants, senior living communities, gyms, and workplaces, that milestone changes the buying calculus. A device that was previously unauthorized now sits inside a formal FDA regulatory framework. But the core safety message has not changed: the strongest protection is a layered emergency plan, not any single tool.

This guide explains what the authorization means, what leading resuscitation authorities recommend, which locations should consider a device, and how to build a responsible organizational setup. If you have already settled the regulatory question and want kit comparisons and current pricing, our LifeVac buying guide is the more useful page.

Is LifeVac FDA approved?

LifeVac is not "FDA approved" in the way that term is used for high-risk (Class III) devices, but it is FDA authorized. On March 4, 2026, the FDA granted LifeVac a De Novo classification under 21 CFR 874.5400, placing it in Class II and creating an entirely new device category called "suction anti-choking device as a second-line treatment." The FDA's decision letter (DEN250012) states the device is intended to resolve choking in a victim with a complete airway obstruction when a current choking protocol has been followed without success. The authorization also carries special controls, including required training materials and an ongoing postmarket surveillance study. In short: authorized and regulated, yes; a first-line replacement for the Heimlich maneuver, no.

Is LifeVac the first and only FDA-authorized anti-choking device?

Yes, as of this writing. The FDA's own safety communication, updated March 4, 2026, states that the agency has authorized one anti-choking device for marketing and distribution in the U.S. Competing suction devices have not reached that status. The FDA issued a warning letter to DeChoker LLC on May 10, 2021, and in October 2025 it issued an import alert listing multiple suction anti-choking devices not authorized for U.S. distribution. Because this is a fast-moving area, treat this status as accurate as of this article's publication date, and confirm current status before relying on it.

What are the age and use limits for LifeVac?

Under the FDA authorization, LifeVac is intended for adult and pediatric choking victims who are at least 1 year of age, and it may be administered by a lay person or a medical professional who is 18 or older. It is a single-use device intended only for complete airway obstruction, and only after a basic life support choking protocol has been attempted without success. It is not indicated for infants under 1 year, and it does not replace the need to call 911.

Does LifeVac actually work?

The honest answer is that real-world reports are encouraging, but the formal evidence base is still limited, and that is exactly why the FDA authorized it as a second-line rather than first-line tool. An independent systematic review published in Resuscitation found that LifeVac has been the most extensively studied suction device, with a combined dislodgement success rate of 94.3 percent on first attempt, while grading the certainty of evidence as very low. A 2025 review in the Journal of Emergency Nursing similarly reported LifeVac had the highest success rate among devices studied but concluded that comparative effectiveness remains unproven. The FDA's authorization requires LifeVac to continue collecting postmarket data on how often the device resolves choking, whether users still called 911 and performed standard protocols first, and its adverse-event profile. The takeaway for organizations: a device can be a valuable backup, but confidence should rest on trained people and clear procedures, not on a percentage.

What do the American Red Cross and American Heart Association say?

Both organizations put manual techniques first. The American Heart Association's 2025 guidelines, published October 22, 2025 in its journal Circulation, recommend alternating five back blows and five abdominal thrusts for choking adults and children, and five back blows with five chest thrusts for infants, since abdominal thrusts are not recommended for infants because of injury risk. The American Red Cross recommends back blows and abdominal or chest thrusts as first-line care and lists suction-based airway clearance devices only as an option to consider when standard interventions have failed or are not feasible, noting that the supporting evidence is low-certainty. Neither organization endorses a specific commercial device. The FDA echoes this hierarchy: follow established rescue protocols first, because they have a high success rate and can be performed immediately, and consider an anti-choking device only as a second option.

How does choking risk break down, and who should care most?

Choking is the fourth leading cause of unintentional injury death in the United States, according to the National Safety Council's Injury Facts. NSC data attribute thousands of choking deaths each year, and the risk is concentrated at the two ends of the age range: very young children and older adults. NSC notes that rates of death rise rapidly at about age 71, with food often responsible, and that living alone, wearing dentures, or having difficulty swallowing raises the danger. That pattern is why choking response is especially important in settings that serve children or older adults.

Which locations should consider anti-choking devices?

Any place where people eat, are supervised in groups, or are at elevated risk should evaluate a layered choking-response plan. High-consideration settings include churches and places of worship that host fellowship meals, schools and daycares, restaurants and commercial kitchens, senior living and nursing homes, gyms and fitness centers, college campuses, hotels, community centers, and workplaces with cafeterias or break rooms. Homes belong on the list too, especially those with young children or older adults. A practical rule: put a device where food is served and where staff can reach it in seconds.

Do schools or restaurants have to have anti-choking devices?

It depends on the state, and the law is changing quickly. Texas became the first state to mandate airway clearance devices in schools when Governor Greg Abbott signed HB 549, the Westyn Bryan Mandrell Act, in June 2025; it requires public-school campuses to make non-invasive airway clearance devices available where students eat, effective for the 2025-2026 school year. New York City passed a school mandate in December 2025. New Jersey's S908 cleared a state Senate committee in March 2025, and Wisconsin has held legislative hearings on a similar measure. Restaurant rules are generally older and focus on posting choking-rescue instructions rather than requiring devices, and they vary by state. Because requirements differ so widely, check your state's current rules before assuming you are compliant, and revisit them periodically. Our 50-state AED law and compliance guide is a good model for how quickly state emergency-readiness requirements evolve.

What is the right organizational emergency setup?

A device alone is not a plan. A responsible setup layers five elements. First, CPR and first-aid training so staff can correctly perform back blows and abdominal thrusts, which remain the first-line response. Second, an AED for sudden cardiac emergencies, which are a separate but related risk in any public space. Third, an authorized anti-choking device such as LifeVac as a second-line tool for when standard techniques fail. Fourth, posted choking-response procedures in visible, high-traffic locations so anyone can follow the steps under pressure. Fifth, immediate 911/EMS activation in every emergency. The device supplements this plan; it never replaces training or professional medical care.

Which LifeVac kit should an organization buy?

Place devices where people eat and where staff can reach them in seconds, and mount them visibly so they are not misplaced. Kits include adult and pediatric masks, and a posted choking emergency poster covers the written-procedure layer of your plan.

For a full comparison of kits, wall mounts and current pricing, see our buying guide: Is LifeVac worth it? Eight reasons to add one to your AED program. Outfitting multiple locations? Call us at 888-541-2337 and we can quote volume on a purchase order.

This article is for general educational purposes and is not medical or legal advice. Always follow current American Red Cross and American Heart Association choking protocols, call 911 in an emergency, and consult your state's regulations and qualified professionals for compliance decisions.